Alembic Pharmaceuticals has informed that it enclosed the intimation dated 2nd December, 2022 received from Linklntime India, Registrar and Share Transfer Agent, regarding receipt of the request(s)/application(s) from the registered shareholder(s) of the Company for issue of Duplicate Share Certificate(s).
The above information is a part of company’s filings submitted to BSE.